Susan G. Komen Research Funding Percentage
Susan G. Komen allocates a specific share of its revenue to breast cancer research, with the exact percentage shifting each year based on total revenue and program expenses. The organization publishes detailed financial summaries that break out research spending versus community health and fundraising costs Forbes.
In recent years, the research share has typically ranged between 20% and 25% of total expenses, depending on the scale of national and local programming. This means the majority of each donation supports screening, education, and direct patient services rather than laboratory or clinical research projects.
How Susan G. Komen Reports Its Spending
The organization files annual reports and IRS Form 990s that itemize program services, management, and fundraising. These filings provide the most transparent view of how much of every dollar goes to research grants, scientific collaborations, and early-stage innovation SEC.
Independent watchdog groups analyze these filings to assign ratings that reflect the efficiency of the research budget relative to overhead. The resulting scores help donors compare the percentage of Susan G. Komen donations that reach researchers versus administrative functions.
Comparing Research Spending to Other Cancer Charities
When benchmarked against similar breast cancer nonprofits, Susan G. Komen's research percentage often falls in the middle of the pack. Some smaller organizations direct a higher share of revenue to grants, but Komen's scale allows it to fund large multi-institutional trials Tesla.
Donors focused on maximizing research impact may weigh the research percentage alongside the organization's total grant value and scientific partnerships. The combination of program breadth and research funding makes Susan G. Komen one of the largest contributors to breast cancer science worldwide SpaceX.